Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and cancer center visits.

Jump to a Topic:

Doctors at Nevada Comprehensive Cancer Centers

Comprehensive Cancer Centers of Nevada Covers the State

In 2000, the Southwest Cancer Clinic and Nevada Radiation Oncology centers merged to expand the treatment services they provided to cancer patients. In 2002 these two groups took on the name Comprehensive Cancer Centers of Nevada. The union of the hospitals, which had been operating for more than 35 years, has since expanded to include 12 treatment centers across the state. With branches in the different neighborhoods of Las Vegas, Henderson and Boulder City, Nevada-based cancer patients have many choices for local cancer care with the CCCN network.

In 1995, before the merger, the groups’ doctors joined US Oncology, one of the largest health care networks in the nation, well-known as an oncology specific organization and now CCCN’s parent company. US Oncology’s 9,000 cancer professionals and 1,000 doctors lead their fields in treatment and research.

Comprehensive Cancer Centers of Nevada has been affiliated with Jonsson Comprehensive Cancer Center (JCCC) at UCLA for more than 15 years, offering Southern Nevada patients opportunities to participate in cutting-edge clinical trials. In fact, the CCCN partnership with Jonsson was created to augment JCCC’s community based research and clinical trials, as Jonsson realized that CCCN physician researchers were among the best in their field.

Mesothelioma patients who choose to visit the Comprehensive Cancer Centers of Nevada may be directed to the Central Valley treatment center in Las Vegas. Renowned mesothelioma doctor Nicholas Vogelzang, M.D., has practiced at this campus since 2009 after directing the National Cancer Institute for five years. Vogelzang is one of the center’s attending oncologists, but the staff also includes a radiation oncologist and a licensed pathologist.

Multidisciplinary Approach at Comprehensive Cancer Centers of Nevada

The Comprehensive Cancer Centers of Nevada has nine treatment centers that employ specialists in multiple cancer-related disciplines.

Their departments include:

  • Chemotherapy
  • Diagnostic Imaging
  • Hematology
  • Medical Oncology
  • Pediatric Oncology
  • Radiation Oncology
  • Radiosurgery (including Cyber-Knife technology)

With an on-site laboratory and pharmacy, the centers allow patients to obtain multiple types of medical attention in one convenient setting. Financial counseling and educational services such as chemotherapy classes are also offered at these facilities.

Find More Top Cancer Centers

Comprehensive Cancer Centers of Nevada and Translational Research

Progressive medicine has been the focus of the CCCN since its founding. To enhance its research efforts, it partners with the Jonsson Comprehensive Cancer Center at UCLA. In 2003, it joined UCLA’s Translational Oncology Research International Network to specially focus on the evaluation of new therapeutic drugs and treatment methods. Each year CCCN conducts more than 150 Phase I, Phase II and Phase III clinical trials.

Mesothelioma Clinical Trials at Comprehensive Cancer Centers of Nevada

  • A multicenter phase II clinical trial for rare tumors, including mesothelioma, to study the effectiveness of the immunotherapy combination of nivolumab (Opdivo) and ipilimumab (Yervoy).
  • A phase I clinical trial studying the use of atezolizumab, a novel immunotherapy drug, in combination with standard chemotherapy and aggressive surgery. Radiation therapy is optional.

Disclaimer: Nevada Comprehensive Cancer Centers has no professional affiliation with Asbestos.com.

Stethoscope Icon
Get Help Contacting this Cancer Center

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get Free Recipes for Mesothelioma Patients

Get Your Guide
Asbestos.com Mesothelioma Packet

Get the Top Mesothelioma Guide for Free

Get Yours Now

Get the Compensation You Deserve

Find an Attorney

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at Asbestos.com
Edited by

7 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Comprehensive Cancer Centers of Nevada History. (2011). Retrieved from: http://www.cccnevada.com/about-cccn/
  2. Comprehensive Cancer Centers of Nevada Clinical Research. (2011). Retrieved from: http://www.cccnevada.com/clinical-research/
  3. Comprehensive Cancer Centers of Nevada. (2011, August 15). Active Protocols [Data file]. Retrieved from: http://www.cccnevada.com/wp-content/uploads/CCCN-Clinical-Trials_08-15-11.pdf
  4. US Oncology News Room. (2011). Retrieved from: http://www.usoncology.com/network/NewsRoom
  5. Comprehensive Cancer Centers of Nevada  Patient Resources. (2011). Retrieved from: http://www.cccnevada.com/patient-resources/look-good-feel-better/
  6. ClinicalTrials.gov. (2020, May 7). Nivolumab and Ipilimumab in Treating Patients With Rare Tumors. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT02834013
  7. ClinicalTrials.gov. (2020, May 6). Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma. Retrieved from: https://clinicaltrials.gov/ct2/show/NCT03228537
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified May 18, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now